144 Participants Needed

Physical Activity for Alzheimer's Disease

(RAATE-MCI Trial)

JR
CH
Overseen ByCallie Hebert, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Pennington Biomedical Research Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Physical activity program for Alzheimer's Disease?

Research shows that exercise programs can help improve daily living activities, physical performance, and reduce depression in people with Alzheimer's disease. These programs can also enhance functional capacity and mobility, making everyday tasks easier for those affected.12345

Is physical activity safe for people with Alzheimer's disease?

Research indicates that exercise programs, including home-based ones, are generally safe for people with Alzheimer's disease, with studies focusing on their feasibility and safety.12678

How is the physical activity program treatment for Alzheimer's disease different from other treatments?

The physical activity program for Alzheimer's disease is unique because it focuses on improving patients' functional abilities and independence through regular exercise, which can be done at home or in care settings, making it more accessible and easier for caregivers to manage compared to traditional medical treatments.124910

What is the purpose of this trial?

The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African American adults aged 60 and older will be recruited.

Research Team

RL

Robert L Newton, Jr., PhD

Principal Investigator

Pennington Biomedical Research

OC

Owen Carmichael, PhD

Principal Investigator

Pennington Biomedical Research

Eligibility Criteria

The RAATE-MCI trial is for African American adults aged 60 or older who self-identify as such, are willing to be randomly assigned to groups, can attend sessions and travel within the study area for a year. They must be physically able to exercise but not currently active, have mild cognitive impairment without severe dementia, and agree to data use after the study.

Inclusion Criteria

Physically capable of exercise
Free of conditions that would make regular exercise unsafe as deemed by the medical investigator
Willing to accept randomization
See 9 more

Exclusion Criteria

I am not willing to sign consent or be randomly assigned to a study group.
I am currently in a heart and lung rehab program.
My diabetes is not under control.
See 11 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are assigned to either a physical activity intervention or a successful aging group for 52 weeks

52 weeks
Regular sessions at Pennington Biomedical or local community facilities

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Physical activity program
  • Successful Aging
Trial Overview This trial tests if physical activity affects Alzheimer's risk factors in older African Americans. Participants will either join a physical activity program or an active control group for one year. The goal is to see how exercise influences cognitive health compared with usual activities.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Successful AgingExperimental Treatment1 Intervention
Low intensity activity program and a healthy aging educational component
Group II: Physical ActivityExperimental Treatment1 Intervention
150 minutes of physical activity weekly

Find a Clinic Near You

Who Is Running the Clinical Trial?

Pennington Biomedical Research Center

Lead Sponsor

Trials
314
Recruited
183,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

A home-based exercise program for patients with Alzheimer's Disease (AD) showed good adherence and a trend towards improved functional performance, particularly in hand function and lower extremity strength, after 6 and 12 weeks.
Despite the positive trends in functional performance, there were also indications of worse depression and lower quality of life ratings among participants, suggesting the need for further research to optimize the intervention.
Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the Maximizing Independence in Dementia (MIND) study.Steinberg, M., Leoutsakos, JM., Podewils, LJ., et al.[2022]
A 12-month exercise program consisting of walking, strength, balance, and flexibility training significantly slowed the decline in the ability to perform activities of daily living (ADLs) in 134 patients with Alzheimer's disease compared to routine medical care.
The exercise program also improved physical performance, as evidenced by better 6-meter walking speed, with no adverse effects reported, highlighting its safety and potential benefits for this population.
Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial.Rolland, Y., Pillard, F., Klapouszczak, A., et al.[2022]
A systematic review of 13 randomized controlled trials involving 811 older adults with Alzheimer's disease found that multimodal exercise significantly improves activities of daily living (ADLs), suggesting it is beneficial for functional capacity in this population.
While multimodal exercise showed positive effects on ADLs, other types of exercise like aerobic and resistance training did not demonstrate significant improvements in mobility, muscle strength, or flexibility, highlighting the importance of tailored exercise programs for older adults with cognitive impairments.
Effectiveness of physical exercise at improving functional capacity in older adults living with Alzheimer's disease: a systematic review of randomized controlled trials.Braz de Oliveira, MP., Moreira Padovez, RFC., Serrรฃo, PRMDS., et al.[2023]

References

Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the Maximizing Independence in Dementia (MIND) study. [2022]
Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. [2022]
Effectiveness of physical exercise at improving functional capacity in older adults living with Alzheimer's disease: a systematic review of randomized controlled trials. [2023]
A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings. [2021]
Benefits of physical exercise for older adults with Alzheimer's disease. [2008]
What are older Latinos told about physical activity and cognition? A content analysis of a top-circulating magazine. [2021]
An integrative review of exercise interventions among community-dwelling adults with Alzheimer's disease. [2020]
Feasibility, safety and preliminary evidence of the effectiveness of a home-based exercise programme for older people with Alzheimer's disease: a pilot randomized controlled trial. [2022]
Feasibility [corrected] of regular physical exercise for patients with moderate to severe Alzheimer disease. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Home-based multimodal exercise program in older people with Alzheimer disease: Randomized controlled trial protocol. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity